Latest Headlines

  1. Catalent To Invest In Additional Biomanufacturing Space In Wisconsin
    1/8/2019

    A global biotechnology company plans to add more than 100 new jobs at its facility in southern Wisconsin.

  2. CDMO Fujifilm Diosynth To Invest In Additional Cell Culture Manufacturing Capacity At North Carolina Facility
    1/8/2019

    FUJIFILM Corporation (President: Kenji Sukeno) announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in order to expand its Bio Contract Development and Manufacturing Organization (CDMO) Business.

  3. Catalent To Invest $200M To Expand Manufacturing Capacity For Biologics
    1/7/2019

    Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced it has commenced a $200M capital investment in its Biologics business to expand drug substance manufacturing capacity and drug product fill/finish capacity due to projected growth among existing and future customers.

  4. AGC Biologics To Triple Biomanufacturing Capacity In US With Future Equipment Purchases
    12/18/2018

    AGC Inc., a world-leading manufacturer of glass, chemicals and high-tech materials, has announced a major expansion of AGC Biologics headquartered in the U.S., a CDMO (*1) subsidiary of the company.

  5. Orchard Therapeutics To Invest $150M Into New Gene Therapy Manufacturing Facility In California
    12/13/2018

    Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, today announced that it has signed a long-term lease agreement to build-out a gene therapy manufacturing facility in Fremont, California.

  6. Histo-Scientific Research Laboratories And Vet Path Services Merge
    12/13/2018

    Histo-Scientific Research Laboratories, Inc. (HSRL), has completed its merger with Vet Path Services (VPS) to create the leading provider of research and pre-clinical histology, pathology and archiving services for the biopharmaceutical, medical device and contract research industries.

  7. Parker Bioscience Filtration Urges Holistic Approach To Tackling Mycoplasma Contamination
    12/13/2018

    Biopharmaceutical manufacturers should consider the advantages of single-use technology in mitigating the risk of Mycoplasma contamination, according to Parker Bioscience Filtration.

  8. Bosch Offers Both Visual Inspection And Leak Testing Systems For Pharma
    12/11/2018

    Bosch offers a wide variety of inspection benchtop solutions applicable to both visual inspection and leak detection of vials, ampoules, syringes, and cartridges.

  9. Lonza To Establish Strategic Biomanufacturing Base In China Using GE Healthcare Solution
    12/11/2018

    Lonza recently announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN).

  10. Easy ELISA Kits Provide Fast IgG Quantitation In 30 Minutes
    12/10/2018

    Cell Sciences, a supplier of high-quality reagents for biological research, announces their line of Easy ELISA kits which provide a rapid and easy method for the quantitative determination of IgG in cell culture supernatant, serum or ascitic fluid.